Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
You move from a pre-filled pen to a vial and syringe
Table of Contents The Trial and What It Measured How Endogenous Hormone Release Differs from Synthetic GLP-1 Drugs How the Extract Spared Muscle While Cutting Fat Tolerability and Side Effects The Research Gap the Study Fills Behavioral Changes and Reduced Food Intake Closing Thoughts The Trial and What It Measured A six-month clinical trial reports that a gut-targeted bitter hop extract, marketed as a natural GLP-1 supplement and the active ingredient in Calocurb , produced more fat loss than a placebo while participants estimated muscle mass held steady
unless they get a small discounts or use a drug savings program
The habits you build here carry you through the harder months
Related Resources Explore additional peptide therapy resources to optimize your metabolic health journey: Semaglutide GLP-1 receptor agonist for appetite control and glucose regulation Tirzepatide Dual GIP/GLP-1 agonist for enhanced metabolic support CJC-1295/Ipamorelin Growth hormone secretagogue for muscle preservation and recovery Tesamorelin GHRH analog targeting visceral adipose tissue reduction Schedule a Peptide Therapy Consultation Discuss your metabolic optimization goals with our medical team
Red flags to watch for The FDA issued 58 warning letters in September 2025 and 30 more in March 2026 to telehealth companies for misleading marketing of compounded GLP-1 products
